BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11146160)

  • 1. Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals.
    Dror Y; Ward AC; Touw IP; Freedman MH
    Exp Hematol; 2000 Dec; 28(12):1381-9. PubMed ID: 11146160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
    McLemore ML; Poursine-Laurent J; Link DC
    J Clin Invest; 1998 Aug; 102(3):483-92. PubMed ID: 9691084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.
    Hermans MH; Antonissen C; Ward AC; Mayen AE; Ploemacher RE; Touw IP
    J Exp Med; 1999 Feb; 189(4):683-92. PubMed ID: 9989983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
    Ward AC; van Aesch YM; Gits J; Schelen AM; de Koning JP; van Leeuwen D; Freedman MH; Touw IP
    J Exp Med; 1999 Aug; 190(4):497-507. PubMed ID: 10449521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia.
    Druhan LJ; Ai J; Massullo P; Kindwall-Keller T; Ranalli MA; Avalos BR
    Blood; 2005 Jan; 105(2):584-91. PubMed ID: 15353486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defects of granulopoiesis in patients with severe congenital neutropenia.
    Nakamura K; Kobayashi M; Konishi N; Kawaguchi H; Miyagawa S; Sato T; Katoh O; Ueda K
    Hiroshima J Med Sci; 2002 Sep; 51(3):63-74. PubMed ID: 12422946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5.
    Millot GA; Svinarchuk F; Lacout C; Vainchenker W; Dumenil D
    Br J Haematol; 2001 Feb; 112(2):449-58. PubMed ID: 11167846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of primitive myeloid progenitor cells expressing granulocyte colony-stimulating factor receptor in patients with severe congenital neutropenia.
    Nakamura K; Kobayashi M; Konishi N; Kawaguchi H; Miyagawa S; Sato T; Toyoda H; Komada Y; Kojima S; Katoh O; Ueda K
    Blood; 2000 Dec; 96(13):4366-9. PubMed ID: 11110716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
    Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
    N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
    Tidow N; Pilz C; Teichmann B; Müller-Brechlin A; Germeshausen M; Kasper B; Rauprich P; Sykora KW; Welte K
    Blood; 1997 Apr; 89(7):2369-75. PubMed ID: 9116280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.
    van de Geijn GJ; Gits J; Aarts LH; Heijmans-Antonissen C; Touw IP
    Blood; 2004 Aug; 104(3):667-74. PubMed ID: 15069015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia.
    Hunter MG; Jacob A; O'donnell LC; Agler A; Druhan LJ; Coggeshall KM; Avalos BR
    J Immunol; 2004 Oct; 173(8):5036-45. PubMed ID: 15470047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia refractory to granulocyte colony-stimulating factor.
    Sinha S; Zhu QS; Romero G; Corey SJ
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):791-6. PubMed ID: 14528102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.
    Ward AC; Hermans MH; Smith L; van Aesch YM; Schelen AM; Antonissen C; Touw IP
    Blood; 1999 Jan; 93(1):113-24. PubMed ID: 9864153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.
    Ward AC; van Aesch YM; Schelen AM; Touw IP
    Blood; 1999 Jan; 93(2):447-58. PubMed ID: 9885206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
    Chakraborty A; Dyer KF; Tweardy DJ
    Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors.
    Monahan JB; Hood WF; Welply JK; Shieh JJ; Polazzi JO; Li X
    Exp Hematol; 2001 Apr; 29(4):416-24. PubMed ID: 11301181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The G-CSF receptor carboxyl terminus, truncated in AML/SCN, is required for induction of a Stat5 protease activity.
    Qiu Y; Zhuang D; MacRae A; Dong F
    Leuk Res; 2005 Oct; 29(10):1153-62. PubMed ID: 16111533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the juxtamembrane intracellular sequence of the granulocyte colony-stimulating factor (G-CSF) receptor gene in a patient with severe congenital neutropenia augments GCSF proliferation activity but not through the MAP kinase cascade.
    Yokoyama T; Okamura S; Asano Y; Kamezaki K; Numata A; Kakumitsu H; Shide K; Nakashima H; Taisuke K; Sekine Y; Mizuno Y; Okamura J; Matsuda T; Harada M; Yoshiyuki N; Shimoda K
    Int J Hematol; 2005 Jul; 82(1):28-34. PubMed ID: 16229088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.